Company / SG&A Expense
Danaher Corporation SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$8.2B
FY2025
5-year range
$5.6B / $8.2B
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
#11 of 158
Health Care
What the data says
Among 158 Health Care companies, Danaher Corporation is in the bottom 7% for sg&a expense. SG&A Expense has fluctuated over the past 10 years, ranging from $5.0B in FY2017 to $8.2B in FY2025.
Based on SEC 10-K filings.
$8.2B in FY2025 with a 5-year CAGR of +8.8%. Top quartile in the Health Care sector.
Increased from $6.8B to $8.2B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +8.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 158This company $8.2B Sector average $175.9B
▼
-95.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.8%, indicating consistent growth.
- In FY2025, sg&a expense increased 6.1% year-over-year.
- Ranks #11 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2B | +6.1% |
| FY2024 | $7.8B | +13.8% |
| FY2023 | $6.8B | -1.1% |
| FY2022 | $6.9B | +23.4% |
| FY2021 | $5.6B | +3.7% |
| FY2020 | $5.4B | -3.5% |
| FY2019 | $5.6B | +3.7% |
| FY2018 | $5.4B | +6.9% |
| FY2017 | $5.0B | -10.3% |
| FY2016 | $5.6B | +18.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026